Dr. Rob S Beanlands, MD
Claim this profileUniversity of Ottawa Heart Institute
Studies Injection Site Arthritis
Studies Cardiovascular Disease
2 reported clinical trials
3 drugs studied
Affiliated Hospitals
Clinical Trials Rob S Beanlands, MD is currently running
Water PET MPI
for Coronary Heart Disease
This a Phase 3, prospective, open-label, multicenter study of \[15-O\]-H2O injection for PET imaging of subjects with suspected CAD. Approximately 182 evaluable participants with suspected CAD referred for testing will be included in the study at approximately 10 study sites in the United States and Europe. Approximately 215 participants will be enrolled to account for an estimated 15% drop-out rate. Screening assessments will occur prior to enrollment to confirm eligibility. All participants will receive two doses of \[15-O\]-H2O as part of a single PET imaging session (one dose at rest and one during pharmacological stress with adenosine). A safety follow-up phone call will occur 24 ± 8 hrs after completion of the \[15-O\]-H2O scan.
Recruiting2 awards Phase 38 criteria
Colchicine
for Cardiovascular Disease in Diabetes
This trial tests colchicine to see if it can reduce inflammation in blood vessel plaques in high-risk patients with diabetes or pre-diabetes who recently had a heart attack or stroke. The goal is to prevent future cardiovascular events by reducing plaque inflammation. Colchicine is an ancient drug with anti-inflammatory effects, historically used for conditions like gout and familial Mediterranean fever, and has shown promise in reducing cardiovascular events by targeting inflammation in blood vessel plaques.
Recruiting1 award Phase 35 criteria
More about Rob S Beanlands, MD
Clinical Trial Related3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Rob S Beanlands, MD has experience with
- Colchicine
- [O-15]-Water PET Cardiac Perfusion Imaging
- [O-15]-Water PET Myocardial Perfusion Imaging (MPI)
Breakdown of trials Rob S Beanlands, MD has run
Injection Site Arthritis
Cardiovascular Disease
Atherosclerosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rob S Beanlands, MD specialize in?
Rob S Beanlands, MD focuses on Injection Site Arthritis and Cardiovascular Disease. In particular, much of their work with Injection Site Arthritis has involved treating patients, or patients who are undergoing treatment.
Is Rob S Beanlands, MD currently recruiting for clinical trials?
Yes, Rob S Beanlands, MD is currently recruiting for 2 clinical trials in Ottawa Ontario. If you're interested in participating, you should apply.
Are there any treatments that Rob S Beanlands, MD has studied deeply?
Yes, Rob S Beanlands, MD has studied treatments such as Colchicine, [O-15]-Water PET Cardiac Perfusion Imaging, [O-15]-Water PET Myocardial Perfusion Imaging (MPI).
What is the best way to schedule an appointment with Rob S Beanlands, MD?
Apply for one of the trials that Rob S Beanlands, MD is conducting.
What is the office address of Rob S Beanlands, MD?
The office of Rob S Beanlands, MD is located at: University of Ottawa Heart Institute, Ottawa, Ontario K1Y 4W7 Canada. This is the address for their practice at the University of Ottawa Heart Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.